SEC 13F Intelligence

Steigerwald, Gordon & Koch Inc. / ELV

Steigerwald, Gordon & Koch Inc.’s Elevance Health Inc Formerly Position

Does Steigerwald, Gordon & Koch Inc. own Elevance Health Inc Formerly (ELV)? Yes — 44.9K shares worth $13M (+1.35% of its 13F portfolio) as of Q1 2026, down from 45.6K shares the prior filed quarter.

Position Value
$13M
Q1 2026
Shares
44.9K
% of Portfolio
+1.35%
Quarters Held
30
currently held

Position History ELV

Reported value by quarter
Q4 ’18: $12MQ4 ’18Q1 ’19: $12MQ2 ’19: $12MQ3 ’19: $10MQ4 ’19: $12MQ4 ’19Q1 ’20: $9MQ2 ’20: $10MQ3 ’20: $11MQ4 ’20: $13MQ4 ’20Q1 ’21: $15MQ2 ’21: $16MQ3 ’21: $16MQ4 ’21: $20MQ4 ’21Q1 ’22: $20MQ2 ’22: $19MQ3 ’22: $18MQ4 ’22: $21MQ4 ’22Q1 ’23: $19MQ2 ’23: $18MQ3 ’23: $18MQ4 ’23: $20MQ4 ’23Q1 ’24: $22MQ2 ’24: $23MQ3 ’24: $22MQ4 ’24: $16MQ4 ’24Q1 ’25: $19MQ2 ’25: $18MQ3 ’25: $15MQ4 ’25: $16MQ4 ’25Q1 ’26: $13Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202644.9K$13M+1.35%
Q4 202545.6K$16M+1.53%
Q3 202545.6K$15M+1.41%
Q2 202545.6K$18M+1.87%
Q1 202544.5K$19M+2.16%
Q4 202444.5K$16M+1.85%
Q3 202443.2K$22M+2.45%
Q2 202442.4K$23M+2.78%
Q1 202441.9K$22M+2.70%
Q4 202341.6K$20M+2.66%
Q3 202341.4K$18M+2.75%
Q2 202341.0K$18M+2.67%
Q1 202340.8K$19M+2.80%
Q4 202240.5K$21M+3.30%
Q3 202240.5K$18M+3.37%
Q2 202240.3K$19M+3.39%
Q1 202241.1K$20M+3.08%
Q4 202142.1K$20M+2.94%
Q3 202141.9K$16M+2.55%
Q2 202142.2K$16M+2.67%
Q1 202141.4K$15M+2.76%
Q4 202041.1K$13M+2.68%
Q3 202040.6K$11M+2.58%
Q2 202039.9K$10M+2.78%
Q1 202039.5K$9M+3.04%
Q4 201940.8K$12M+2.90%
Q3 201941.0K$10M+2.51%
Q2 201941.6K$12M+3.04%
Q1 201943.0K$12M+3.26%
Q4 201847.4K$12M+3.70%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Steigerwald, Gordon & Koch Inc.’s full portfolio or all institutional holders of ELV.